SCHEMBL23745802

SCHEMBL23745802

Cc1cccc(C(CC(=O)NC2CCNCC2)c2cn(CC3CCCCC3)c3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.42
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ICMT O60725 1/20 0.38
CCR1 P32246 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37
IDO1 P14902 2/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23722145 0.99 CNR1 (0.41) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745461 0.99 CNR1 (0.41) CNR1KMT2ACYP3A4HPGDCYP2C19
Hydrochloric Acid SCHEMBL23722020 0.98 CNR1 (0.40) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745572 0.96 ICMT (0.41) CNR1KMT2ACYP3A4HPGDCYP2C19
Hydrochloric Acid SCHEMBL23721918 0.95 ICMT (0.41) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23722152 0.94 KMT2A (0.46) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745655 0.93 CNR2 (0.42) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745762 0.92 CNR1 (0.43) CNR1ICMTCNR2
Hydrochloric Acid SCHEMBL23721917 0.92 CNR2 (0.41) CNR1KMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745476 0.91 CNR1 (0.42) CNR1KMT2ACYP3A4HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CNR1 1651/4885KMT2A 4684/4885CYP3A4 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.